Blue Cell Therapeutics appoints highly experienced pharma and biotech executive Olav Hellebø as Chairman of the Board of Directors

Seasoned executive with three decades of experience in pharma and biotechBiotech board experience from Cytovation ASA, Antev Ltd, and Calliditas Therapeutics, and governance / senior leadership experience from UCB, Novartis and Schering-Plough (now Merck)Appointment comes as Blue Cell looks to progress its lead candidate, allogeneic stem cell treatment BlueC-231, into Phase 1/2a clinical trials for the treatment of severe erectile dysfunction (ED) following prostate cancer surgeryView original content:https://www.prnewswire.co.uk/news-releases/blue-cell-therapeutics-appoints-highly-experienced-pharma-and-biotech-executive-olav-hellebo-as-chairman-of-the-board-of-directors-302545521.html